Overview

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the efficacy and safety profiles of the test product containing 2 mg/mL ciprofloxacin hydrochloride associated with 10 mg/mL of hydrocortisone with the reference product Cipro HC®, in patients with acute otitis externa.
Phase:
Phase 3
Details
Lead Sponsor:
Farmoquimica S.A.
Collaborator:
Pharmagenix Projetos em Medicina Farmacêutica Ltda.
Treatments:
Ciprofloxacin
Ciprofloxacin, hydrocortisone drug combination
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate